Sneha joined Eradigm in April 2022 as an Associate Consultant, bringing to the team her experience in infectious diseases research and a strive for contributing to global healthcare enhancement.
Sneha worked in consulting projects spanning therapeutic areas such as oncology, infectious diseases, haematology and rare diseases, and devices. She was involved in conducting competitive intelligence for multiple projects delivered on market assessment, data analytics, KOL profiling and social media analytics geographies including US, EU, LATAM and APAC markets. She was responsible for project management and driving multiple strategic intelligence engagements for year-long tracker projects to help clients understand and strategize their competition. She has also gained profound experience in collecting comprehensive market, competitor and stakeholder evidence through desk-based interviewing and elicitation; conducting research and analysing industry trends and data, create competitive landscape to understand the healthcare scenario, and comprehend reimbursement policies in global pharmaceutical market.
By qualification, Sneha is a medical microbiologist and obtained her PhD in infectious diseases with her research in the in overlapping fields of immunology and host-pathogen interaction, from the Medical University of Innsbruck, Austria. Her thesis decoded the role of Shiga toxin produced by Enterohemorrhagic E. coli (EHEC) in Haemolytic Uremic Syndrome (HUS). Prior to that, she secured her masters in Applied Microbiology from the VIT University, India, and bachelors in Microbiology (Honours) from the University of Delhi, India.
Outside of work, Sneha loves to travel and enjoys being acquainted with new cultures and trends. She loves to sing and has also lent her voice to a few short films as a playback singer. She is also trained in Indian dance forms, which she feels keeps her connected to her roots. Sneha loves to try out new cuisines and try her hands at cooking every once in a while.
Sneha believes in the idea of translational research with direct bench-to-bedside significance, and with her cumulative experience, would like to contribute to create a positive impact in the global healthcare space.